 |
| Left to Right: Dr. Kim Littefield, assistant vice president for research development and learning; Dr. Mike Finan, MCI director; Dr. Luda Rachek, assistant professor in the USA College of Medicine, department of pharmacology; Abraham "Abe" Mitchell; Dr. Mark Taylor, associate professor in the USA College of Medicine, department of physiology and cell biology; Dr. Glen Borchert, assistant professor in the USA department of biology; and, Dr. Laurie Owen, MCI associate director for basic and translational sciences, and Barbara Colle Chair for oncological sciences. |
Dr. Mark Taylor, associate professor of physiology and cell biology at the USA College of Medicine, was awarded a one-year grant totaling $59,640. Dr. Taylor was recognized for his work on “Ca2+ Signal Patterning in Cancer.” Dr. Taylor works in collaboration with Dr. Garry Piazza from the USA Mitchell Cancer Institute and Dr. Lalita Shevde-Samant from the University of Alabama at Birmingham.
Dr. Luda Rachek, assistant professor of pharmacology at the USA College of Medicine, also was awarded a one-year grant totaling $60,000. Dr. Rachek’s project is “Targeting TAT-DNA repair enzymes into mitochondria as a novel therapeutic strategy for breast cancer progression.” Dr. Rachek is working in collaboration with Dr. Ming Tan, a faculty member at the USA Mitchell Cancer Institute.
A third one-year grant award was presented to Dr. Glen Borchert, assistant professor of biology at USA, for his work on “Discovery and Characterization of MicroRNAs with Undescribed Roles in Breast Cancer Pathology.” Dr. Borchert is collaborating with Dr. Yaguang Xi, a faculty member at the USA Mitchell Cancer Institute.
Abraham Mitchell created the fund with a $1 million gift to the University, hoping to encourage cancer-related and cancer-relevant research by scientists in many different University departments.
